SCHEMBL2299451

SCHEMBL2299451

CC(O)CC1CCN(C(=O)c2ccc3nc(Cl)nc(N4CCOCC4)c3n2)CC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.40
HRH3 Q9Y5N1 2/20 0.40
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
KMT2A Q03164 1/20 0.36
RORC P51449 1/20 0.36
KDM4A O75164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
PIK3CD O00329 5/20 0.34
SCN9A Q15858 2/20 0.34
PIK3CA P42336 1/20 0.34
AVPR1B P47901 1/20 0.34
CCNC P24863 1/20 0.33
CDK8 P49336 1/20 0.33
HDAC1 Q13547 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2272805 0.82 PIK3CD (0.46) HRH3KDM4APIK3CDSCN9APIK3CA
SCHEMBL2268269 0.77 PIK3CD (0.42) KDM4EMEN1ALDH1A1GAAMAPT
SCHEMBL2274088 0.76 PIK3CA (0.41) KDM4EMEN1ALDH1A1GAAMAPT
SCHEMBL2274542 0.76 SMN1; SMN2 (0.43) KDM4ESMN1; SMN2PIK3CDPIK3CA
SCHEMBL2270379 0.76 PIK3CA (0.54) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL2270052 0.73 PIK3CA (0.43) KDM4ESMN1; SMN2PIK3CDPIK3CA
SCHEMBL2271370 0.69 PTGES (0.44) MEN1ALDH1A1MAPTKMT2ASMN1; SMN2
SCHEMBL2274934 0.69 HDAC1 (0.39) MEN1ALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL2274942 0.69 HDAC1 (0.39) MEN1ALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL2272862 0.69 SMN1; SMN2 (0.41) HRH3KDM4EMEN1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2539337-A1 PYRIDO[3,2-D]PYRIMIDINE PI3K DELTA INHIBITOR COMPOUNDS AND METHODS OF USE F. Hoffmann-La Roche AG (CH) 2013-01-02 EP disclosed
WO-2011101429-A1 PYRIDO[3,2-D]PYRIMIDINE PI3K DELTA INHIBITOR COMPOUNDS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2011-08-25 WO disclosed